| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-10 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.36 | 9e-06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-05 |